Today, July 23, a panel of advisers to the FDA voted to place a widely used peptide called #BPC157 on a list that would allow broader pharmacy #compounding BPC-157 is a synthetic #peptide that promotes the growth of new blood vessels and collagen production, which may speed the recovery time of injured muscles, tendons, and ligaments
It is not engineered to hit the NF-kB pathway with the specificity that KPV does
In laboratory and pre-clinical research settings, the Wolverine Stack is studied for its dual-phase coverage of the tissue repair cascade with BPC-157 addressing the vascular, fibroblast, and ECM phases of repair, and TB-500 addressing the cellular migration, cytoskeletal, and stem cell mobilisation phases
More is not always better, and thoughtful protocol design often outperforms brute force approaches over time